MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told
In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending
Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher
Manipulating The Therapeutic Index Clinical Trials Goal: Hellman
NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen
HHS Carcinogen Guidelines Draft
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
- In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
